Search

Coronavirus crisis

Recce Pharmaceuticals is among dozens of WA-founded biotech companies that are making serious waves in the medical research sector, with COVID-19 the latest disease in its sights...

read full article

img 1

Nature Biopharma

New class of synthetic antibiotics set to tackle superbugs PERTH, Australia – A new class of synthetic antibiotics with broad-spectrum activity is being developed by Sydney-based...

read full article

img 1

Fighting Antibiotic Resistance

The world needs new classes of antibiotics Antibiotics
The world needs new classes of antibiotics Antibiotics are used as our frontline treatment...

read full article

img 1

BioWorld

Recce nears clinic with ‘master key’ antibiotic to take on superbugs PERTH, Australia – A new class of synthetic antibiotics with broad-spectrum activity is being developed by Sydney-based...

read full article

img 1

The Australian

Australia’s Recce strives for immune-proof super-antibiotic Introductory offers to be billed as follows: The Australian Digital Subscription costs 50c per day, billed monthly (min cost up...

read full article

img 1

The West Australian

WA tests synthetic antibiotic A Perth-based pharmaceutical research company is a step closer to developing a new class of synthetic antibiotics to overcome superbugs. Recce Limited has started ...

read full article

img 1

S&P Global

Small companies play big role in search for superbug killers Superbugs are quickly becoming a top health concern, yet there has been a roughly 30-year dry spell in antibiotic molecule discovery...

read full article

img 1

Sky Business News

Interview with Peter Switzer One of the worrying trends in hospitals are superbugs, raising question marks over the efficacy of antibiotics. Listed company Recce target is targeting this issue ..

read full article

Sign up for news and updates

Receive news and information direct to your inbox.